New US prevention guidelines focus on overall risk of cardiovascular disease
McCarthy, M.
Bmj 347: F6858
2013
ISSN/ISBN: 0959-8138 PMID: 24231274 Document Number: 665850
Document emailed within 1 workday
Related Documents
Kelly, S.C.; Gonzalo, R.; Petrasko, M. 2014: A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines South Dakota medicine: the journal of the South Dakota State Medical Association 67(8): 320-323De Backer, G.; De Bacquer, D.; Brohet, C.; De Ceukelier, S.; Franck, A.; Krzentowsky, G.; Legat, P.; Pochet, J.M.; Scheen, A. 2005: Guidelines on cardiovascular disease prevention in clinical practice Revue Medicale de Liege 60(3): 163-172
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Goh, L.G.; Chua, T.; Kang, V.; Kwong, K.H.; Lim, W.Y.; Low, L.P.; Pereira, J.; Venketasubramanian, N.; Sethi, S.K.; Sum, C.F.; Tan, C.L.B.; Tan, H.K.; Tan, S.M.J.; Wong, T.K.M. 2011: Ministry of health clinical practice guidelines: screening of cardiovascular disease and risk factors Singapore Medical Journal 52(3): 220-5 Quiz 226-7
Brohet, C. 1995: Risk factors and primary prevention of cardiovascular disease Journal de Pharmacie de Belgique 50(1): 20-24
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Henriquez, D.; Dikow, R.; Ritz, E. 2004: Cardiovascular disease in chronic renal failure. Risk factors and prevention Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl. 4: 34-39
Bellomo, A.; Mancinella, M.; Troisi, G.; Marigliano, V. 2009: Relationship between atrial fibrillation and other cardiovascular risk factors in Alzheimer's disease. New prevention opportunities Recenti Progressi in Medicina 100(3): 124-126
2011: Chinese guidelines for prevention of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 39(1): 3-22
Aghaeishahsavari, M.; Noroozianavval, M.; Veisi, P.; Parizad, R.; Samadikhah, J. 2006: Cardiovascular disease risk factors in patients with confirmed cardiovascular disease Saudi Medical Journal 27(9): 1358-1361
Vigna, G.Battista.; Fellin, R. 2003: Dyslipidemia and global cardiovascular risk: treatment guidelines Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4 Suppl. 7: 4s
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Cannon, R.O. 1998: Role of nitric oxide in cardiovascular disease: focus on the endothelium Clinical Chemistry 44(8 Part 2): 1809-1819
Ortega Anta, R.M. 1999: The benefits and risks of following dietary guidelines aimed at decreasing cardiovascular risk from childhood Anales Espanoles de Pediatria 50(6): 576-580
Srisuwan, P. 2013: Primary prevention of dementia: focus on modifiable risk factors Journal of the Medical Association of Thailand 96(2): 251-258
Huo, Y.; Li, X.Y. 2018: Deepen our thoughts on the prevention of cardiovascular disease and actively contribute to the earlier appearance of the turning point noting the reduced prevalence of cardiovascular diseases Zhonghua Xin Xue Guan Bing Za Zhi 46(1): 3-6
Kleinert, S. 1999: HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation Lancet 354(9181): 841
2012: Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk MMW Fortschritte der Medizin 154(3): 82-83
Larosa, J.H.; Larosa, J.C. 2006: Coronary heart disease prevention in women: focus on lipids Minerva Cardioangiologica 54(3): 311-322
Elliott, H.L. 1998: Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point? Journal of Cardiovascular Pharmacology 32(Suppl 3): S74-S77